March is Colorectal Cancer Awareness Month, a time to stress the importance of screening and early treatment in improving ...

California Republicans vie to capitalize on their November victories and break Democratic supermajority while balancing Trump ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED", the "Company" or "we") (HKEX: 13; Nasdaq/AIM: HCM) today reports its financial r ...

Pharmexcil urges a review of a new rule for drug exports in India, which requires a product registration certificate from the importing ... which necessitates obtaining approval status from other ...

Retiring in Thailand can be affordable and enjoyable, but many retirees lose money due to common mistakes. High living costs, scams, and unexpected expenses can quickly drain savings. There are five ...

FDA accepts Capricor's Biologics License Application for priority review, advancing deramiocel for DMD cardiomyopathy.

On March 19, the Food and Drug Administration granted traditional approval to pembrolizumab, or Keytruda, marketed by Merck (MRK), with ...

Johnson & Johnson's nipocalimab earns FDA Fast Track status for Sjögren's disease, speeding development and review for unmet medical needs.

CAMBRIDGE, Mass. – Korro Bio, Inc. (NASDAQ:KRRO), a clinical-stage biopharmaceutical company with a market capitalization of $231 million, has received orphan drug designation from the U.S. Food ...

The FDA’s ODD status provides benefits to drug developers, including potential market exclusivity for seven years, tax credits for clinical trials, and exemptions from certain regulatory fees. This ...

The FDA’s ODD program supports the development of treatments for rare diseases that affect fewer than 200,000 people in the U.S. Benefits of the designation include tax credits, FDA application ...

The FDA granted the application Breakthrough Therapy Designation and Priority Review status and assigned a Prescription Drug User Fee Act goal date of June 23, 2025. See what stocks are receiving ...